Squamous cell carcinoma antigen levels in women with cervical cancer

被引：0
|
作者：
Isikhuemen, M. [1 ]
Ezeanochie, M. [1 ]
Okonkwo, C. [1 ]
Okonofua, F. [1 ]
机构：
[1] Univ Benin Teaching Hosp, Benin, Benin
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2024年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
OS-58
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [21] PERFORMANCE CHARACTERISTICS OF SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) EIA ASSAY IN CERVICAL CANCER
    Dahlen, U.
    de Bruijn, H. W. A.
    Hall, C.
    Nilsson, O.
    Einarsson, R.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3477 - 3478
  • [22] IMMUNOCYTOCHEMICAL DETECTION OF ANTIGEN ASSOCIATED WITH SQUAMOUS-CELL CERVICAL-CANCER IN WOMEN
    IEVLEVA, ES
    MARSHUTINA, NV
    AGEENKO, AI
    ZUKERMAN, BG
    EKSPERIMENTALNAYA ONKOLOGIYA, 1990, 12 (04): : 65 - 67
  • [23] Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma
    Chen, Peng
    Jiao, Liang
    Ren, Fang
    Wang, Dan-Bo
    BMC CANCER, 2020, 20 (01)
  • [24] Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma
    Peng Chen
    Liang Jiao
    Fang Ren
    Dan-Bo Wang
    BMC Cancer, 20
  • [25] Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice
    Shimura, Kotaro
    Mabuchi, Seiji
    Yokoi, Takeshi
    Sasano, Tomoyuki
    Sawada, Kenjirou
    Hamasaki, Toshimitsu
    Kimura, Tadashi
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2013, 24 (04) : 321 - 329
  • [26] The change of squamous cell carcinoma antigen levels can predict tumor recurrence and survival in patients with cervical cancer with definitive chemoradiotherapy
    Lee, S.
    Lee, J.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 198 - 198
  • [27] Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer
    Reesink-Peters, N
    van der Velden, J
    ten Hoor, KA
    Boezen, HM
    de Vries, EGE
    Schilthuis, MS
    Mourits, MJE
    Nijman, HW
    Aalders, JG
    Hollema, H
    Pras, E
    Duk, JM
    van der Zee, AGJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1455 - 1462
  • [28] COMPARE THE LEVEL OF SQUAMOUS CELL CARCINOMA ANTIGEN IN SERUM AND LOCAL IMMUNITY OF THE REPRODUCTIVE TRACT IN WOMEN WITH INVASIVE FORM OF CERVICAL CANCER
    Baturina, I. L.
    Orner, I. U.
    Zotova, M. A.
    Abramovskih, O. S.
    Nikushkina, K., V
    Telesheva, L. F.
    INFEKTSIYA I IMMUNITET, 2014, 4 (02): : 143 - 147
  • [29] The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy
    Yoon, S. M.
    Shin, K. H.
    Kim, J.-Y.
    Seo, S. S.
    Park, S.-Y.
    Kang, S.
    Cho, K. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (04) : 872 - 878
  • [30] UTILITY OF SQUAMOUS-CELL CARCINOMA ANTIGEN (SCC) IN PATIENTS WITH CERVICAL SQUAMOUS-CELL CARCINOMA (CSCC)
    SENEKJIAN, EK
    YOUNG, JM
    WEISER, P
    HERBST, AL
    MAZUREK, C
    GYNECOLOGIC ONCOLOGY, 1986, 23 (02) : 248 - 249
12345